Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Hydroxyurea |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Hydroxyurea
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Ibandronate Sodium |
Bisphosphonate | Both (Solid & Hematologic) | ||
|
Molecule
Ibandronate Sodium
Therapeutic Category
Bone-Modifying Agent
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Bisphosphonate |
||||
Idarubicin |
Anthracycline / Anthracenedione | Both (Solid & Hematologic) | ||
|
Molecule
Idarubicin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
||||
Ifosfamide |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Ifosfamide
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Imipenem-Cilastatin |
Antibiotic (Febrile Neutropenia) | Both (Solid & Hematologic) | ||
|
Molecule
Imipenem-Cilastatin
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antibiotic (Febrile Neutropenia) |
||||
Imlunestrant |
Selective Estrogen Receptor Degrader (SERD) | Solid Tumour (Breast) | ||
|
Molecule
Imlunestrant
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
||||
Immune Globulin IV (Onc/Hematology Use) |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Immune Globulin IV (Onc/Hematology Use)
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
Irinotecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Irinotecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Iron Sucrose |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Iron Sucrose
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
Isavuconazole |
Antifungal (Febrile Neutropenia) | Both (Solid & Hematologic) | ||
|
Molecule
Isavuconazole
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antifungal (Febrile Neutropenia) |
||||
Isotretinoin (Onc Adjacent) |
Retinoid / Arsenical | Hematologic (APL) / Solid Tumour | ||
|
Molecule
Isotretinoin (Onc Adjacent)
Therapeutic Category
Differentiating Agent
Oncology Type
Hematologic (APL) / Solid Tumour
Drug Class / Mechanism
Retinoid / Arsenical |
||||
Itraconazole |
Antifungal (Febrile Neutropenia) | Both (Solid & Hematologic) | ||
|
Molecule
Itraconazole
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antifungal (Febrile Neutropenia) |
||||
HydroxyureaCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
Ibandronate SodiumBone-Modifying Agent |
|
|
Therapeutic Category
Bone-Modifying Agent
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Bisphosphonate |
|
IdarubicinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anthracycline / Anthracenedione |
|
IfosfamideCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
Imipenem-CilastatinSupportive Care (Anti-Infective) |
|
|
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antibiotic (Febrile Neutropenia) |
|
ImlunestrantHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
|
Immune Globulin IV (Onc/Hematology Use)Supportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|
IrinotecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
Iron SucroseSupportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|
IsavuconazoleSupportive Care (Anti-Infective) |
|
|
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antifungal (Febrile Neutropenia) |
|
Isotretinoin (Onc Adjacent)Differentiating Agent |
|
|
Therapeutic Category
Differentiating Agent
Oncology Type
Hematologic (APL) / Solid Tumour
Drug Class / Mechanism
Retinoid / Arsenical |
|
ItraconazoleSupportive Care (Anti-Infective) |
|
|
Therapeutic Category
Supportive Care (Anti-Infective)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antifungal (Febrile Neutropenia) |
|